Evidence map›Paper›PMID 34255231›Full record

Observational studyEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.

Hélène Mascitti, Patrick Jourdain, Alexandre Bleibtreu, Luc Jaulmes, Agnès Dechartres, Xavier Lescure, Youri Yordanov, Aurélien Dinh, AP-HP/Universities/INSERM COVID-19 research collaboration

Open access · bronzeAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Hélène MascittiInfectious Disease Department, University Hospital R. Poincaré, APHP, Paris Saclay University, 104 Bd R. Poincaré, 92380, Garches, France.
Patrick JourdainCardiology Department, University Hospital Kremlin Bicêtre, APHP, Paris Saclay University, 104 Bd R. Poincaré, 92380, Garches, France.
Alexandre BleibtreuInfectious Disease Department, University Hospital Pitié Salpétrière, APHP, Paris University, Paris, France.
Luc JaulmesCentre de Pharmaco-Épidémiologie (Cephepi), Pitié Salpêtrière Hospital, Paris, France.
Agnès DechartresSorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie Et de Santé Publique, UMR-S 1136, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie de L'AP-HP (Cephepi), Paris, France.
Xavier LescureInfectious Disease Department, University Hospital Bichat, APHP, Paris University, Paris, France.
Youri YordanovEmergency Department, University Hospital Saint Antoine, APHP, Paris University, Paris, France.
Aurélien DinhInfectious Disease Department, University Hospital R. Poincaré, APHP, Paris Saclay University, 104 Bd R. Poincaré, 92380, Garches, France. aurelien.dinh@aphp.fr.
AP-HP/Universities/INSERM COVID-19 research collaboration
Pitié-Salpêtrière Hospital · FRSorbonne Université · FRUniversité Paris-Saclay · FRAssistance Publique – Hôpitaux de Paris · FRDélégation Paris 7 · FRHôpital Bichat-Claude-Bernard · FRHôpital Raymond-Poincaré · FRSorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a large regional observational cohort study of adult (≥ 18 years), outpatients with COVID-19, prevalence, characteristics, and outcome of patients with rash and/or chilblain-like lesions (CLL), compared with population without cutaneous features, were studied. In total, 28,957 outpatients were included; the prevalence of rash and CCL were 9.5% and 3.7%, respectively. Presence of rash was significantly associated with presence of asthenia, shivers or myalgia, respiratory and gastro-intestinal symptoms, and anosmia/ageusia. The presence of CCL was associated with chest pain, chest oppression, nausea/vomiting, and anosmia/ageusia. Patients with CCL were significantly less prone to an unfavourable outcome (hospitalization or death).

Indexed as

AdultAgedChilblainsCohort StudiesCOVID-19ExanthemaFemaleHumansMaleMiddle AgedOutpatientsPrognosisSARS-CoV-2Chilblain-like lesionCOVID19HospitalizationRashRisk factors

Identifiers

PMID34255231
PMCPMC8276548
OpenAlexW3182438016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.